Clinical Trial Update: Temsirolimus and Bevacizumab in Treating Patients With Stage III or Stage IV Malignant Melanoma [Phase 2]

View source ↗

Summary

This is a Phase 2 trial evaluating temsirolimus in combination with bevacizumab for stage III/IV malignant melanoma; results have been posted after study comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Melanoma

Drugs mentioned

• Avastin (bevacizumab)
• Torisel (Temsirolimus)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Recurrent Melanoma, Stage IIIB Skin Melanoma | Phase 2 | Status: COMPLETED | Results posted: 2017-06-09